We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Destiny Pharma Plc | LSE:DEST | London | Ordinary Share | GB00BDHSP575 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 2.50 | 3.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/11/2024 11:31 | I've skim-read the documents on Co.s House of 19 October. It's not all over yet by any stretch... Sale negotiations ongoing with "multiple parties". Creditors to be paid in full with the intention to convert to a CVL to allow a dividend payment if appropriate once outcome of sale process is known. | chrysalis99 | |
04/11/2024 08:41 | Mystery why Rudd bought 1.2m shares in August. | chrysalis99 | |
28/10/2024 13:46 | It's game over! Check Companies House for Administrators update. Such a shame - heaven forbid we end up with an AMR strain that wreaks havoc and yet could have been solved with DEST's product line. | cloudwars | |
30/8/2024 16:24 | I guess it depends if there is more than one interested party. ??? A low ball offer given the stage they've got to could easily go to £50m. I'm sure Tovey wanted to take the big boys on and run with it as a listed entity but that wasn't to be. | cloudwars | |
30/8/2024 14:04 | Ram out of cash and couldn't raise without huge dilution . The company over valued itself and thought it would do better privately but reality was very different . Now it will be sold off for peanuts and the boys probably get jobs with who buys it . Much will have been planned out already imo . Totally shafted shareholders yet again | bones698 | |
30/8/2024 13:47 | But given the extensive fundraising/partners | chrysalis99 | |
29/8/2024 16:41 | Because he knew of the pending FDA status re XF Dermal | cloudwars | |
29/8/2024 13:56 | Administration may have been a prudent move given the circumstances and it does not necessarily mean game over for shareholders | timbo003 | |
29/8/2024 13:28 | That's the mystery. Why did Rudd buy a big chunk of shares a few weeks before the board put the company into administration? | chrysalis99 | |
28/8/2024 19:11 | Why not contact JP Jenkins the broker who are dealing on a matched market basis who may have a seller for your request | oliversydney | |
28/8/2024 16:39 | I’m in the market for a few 100k at 3 Anyone ? | washingmachine | |
28/8/2024 16:37 | It may be worth buying a few If their is any sellers | washingmachine | |
28/8/2024 16:32 | What a snip for Sebala this might me. If sizeable Royalties are down the road (IF) why not nip them in the bud and acquire Dest...... | carlisle44 | |
28/8/2024 12:55 | I think the share holders will be alright as the company had money in the bank and little in the way of debt.Also I doubt that Nigel Rudd would have bought a large chunk of shares in the market only to see it vanish a few weeks later And the FDA approval today is big news | oliversydney | |
28/8/2024 11:41 | Still activity and interest despite the company now being delisted and in administration, although I'm not sure that shareholders will end up with much (or anything) even if the administrators achieve an optimal outcome: It is good to see that there is renewed interest in inhaled XF drugs for Cystic Fibrosis, I have always thought that CF might be the best way in for first approval and the news today concerning QIDP status for XF-73 Dermal to treat burn wound infections will help attract interest from potential investors or acquirers | timbo003 | |
25/8/2024 08:37 | Hats off for calling this correct Bones i must admit with the advance phase 3 products they had i never expected administration. im guessing pharma simply wasnt interested in the space DEST was working in. Will be interesting to see who eventually gets hold of the Tech. Thankfully no damage done, however GL to those who may have taken a hit. | john henry | |
13/8/2024 09:00 | Terminated. | terminator101 | |
12/8/2024 16:25 | 10p you say. Yet this pile of pish has gone into obscurity without trace. | terminator101 | |
10/8/2024 12:52 | GEX: Next big thing is Helium. Currently 15p with broker target £321 if they pull it off this December. Https: //www.youtube.com/wa | batiatus | |
09/8/2024 11:36 | Zen do you think that the issued share capital will be reduced in number too? | carlisle44 | |
09/8/2024 10:31 | Personally I think they already have a pre-agreement in place with an investor(s), otherwise why would one go through all the pain and cost of delisting on a suggestion. After delisting I suspect magically funding to arrive. | zen12 | |
09/8/2024 09:51 | I've bought more and will end up with a share certificate. Any future gains I'm happy to pay tax on. | cloudwars | |
09/8/2024 07:25 | Some interesting posts on the Lse forum. Holding these delisted shares could be problematic. I've sold. | jias | |
06/8/2024 12:14 | If they get this right then they'll get the funding - probably from the US via p.e - get Phase 3 completed and then look to list on the NASDAQ - I've bought in from low levels and am happy to tuck these away for a few years. | cloudwars |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions